The Harvest Podcast

Got something to say to this podcast? Send a voicemail, and you might hear yourself on the next episode!Fusion energy has long been viewed as a technology of the future. Brent Nelson, CEO of Kepler Fusion Technologies, believes that future is arriving faster than many expect.In this episode, Carmel Fisher sits down with Nelson to discuss the company's aneutronic fusion platform, its strategy to deploy a fully operational 100-megawatt reactor, and the milestones already underway, including a 5-megawatt pre-production unit and commercial projects targeting data centers and industrial campuses.The conversation explores commercialization timelines, regulatory considerations, behind-the-meter deployment opportunities, and the broader implications for energy infrastructure investors as fusion moves from laboratory science toward revenue-generating applications.Disclaimer:The Harvest podcast is for informational and educational purposes only. The views and opinions expressed in this podcast are those of the hosts and guests and may constitute forward-looking statements. These statements, and any others made throughout the Harvest Podcast episodes, do not necessarily reflect the official policy or position of any company or institution mentioned.The content of this podcast does not constitute investment, legal, or tax advice. Any strategies or investment ideas discussed may not be suitable for all investors. Listeners should conduct their own research and consult with professional advisors before making any investment decisions.Past performance is not indicative of future results. The host, guests, and producers of this podcast may hold positions in the securities discussed. This podcast may contain forward-looking statements that are subject to risks and uncertainties. Actual results may differ materially from those projected in these forward-looking statements.Investing in securities involves risk, including the potential loss of principal. Please be aware that the stock market can be volatile and investment values can fluctuate.By listening to this podcast, you agree to not hold the host, guests, producers, or any affiliated companies liable for any investment decisions you make.Always do your own due diligence and invest responsibly.

Got something to say to this podcast? Send a voicemail, and you might hear yourself on the next episode!This conversation hosted by Carmel Fisher, focused on Patrick Gruhn, CEO of Perpetuals, discussing the company's regulated exchange for multi-assets, including its unique features and strategic positioning.Patrick explained Perpetuals' regulatory compliance, AI-powered risk analysis, and competitive advantages over unregulated offshore exchanges. He highlighted the company's barrier futures product, which addresses market liquidity issues and offers a safer trading environment for clients.Patrick also touched on Perpetuals' expansion plans, including tokenized securities and potential partnerships with African countries for rare metal tokenization.The conversation concluded with Patrick's reflections on the importance of strategic relationships and networking opportunities, such as the World Liberty Forum at Mar-a-Lago.Disclaimer:The Harvest podcast is for informational and educational purposes only. The views and opinions expressed in this podcast are those of the hosts and guests and may constitute forward-looking statements. These statements, and any others made throughout the Harvest Podcast episodes, do not necessarily reflect the official policy or position of any company or institution mentioned.The content of this podcast does not constitute investment, legal, or tax advice. Any strategies or investment ideas discussed may not be suitable for all investors. Listeners should conduct their own research and consult with professional advisors before making any investment decisions.Past performance is not indicative of future results. The host, guests, and producers of this podcast may hold positions in the securities discussed. This podcast may contain forward-looking statements that are subject to risks and uncertainties. Actual results may differ materially from those projected in these forward-looking statements.Investing in securities involves risk, including the potential loss of principal. Please be aware that the stock market can be volatile and investment values can fluctuate.By listening to this podcast, you agree to not hold the host, guests, producers, or any affiliated companies liable for any investment decisions you make.Always do your own due diligence and invest responsibly.

Got something to say to this podcast? Send a voicemail, and you might hear yourself on the next episode!Watch and Subscribe on Youtube: https://www.youtube.com/@TheHarvestPodcastwithCarmel In this episode, Carmel Fisher sits down with former Calidi Biotherapeutics,CEO Stephen Thesing to explore the company's innovative approach to cancer treatment through oncolytic virus therapy.They discuss Calidi's three groundbreaking platforms - NeuroNova, SuperNova, and RTNova - and dive into their recent $2 million capital raise and upcoming Phase 1b/2 trial at Northwestern University.Thesing shares insights on how their stem cell delivery technology could revolutionize brain cancer treatment and explains the potential of their new RTNova platform for systemic delivery.They also explore the company's strategic priorities in the evolving biotech funding landscape and their position in the growing oncolytic virus market.Disclaimer:The Harvest podcast is for informational and educational purposes only. The views and opinions expressed in this podcast are those of the hosts and guests and do not necessarily reflect the official policy or position of any company or institution mentioned.The content of this podcast does not constitute investment, legal, or tax advice. Any strategies or investment ideas discussed may not be suitable for all investors. Listeners should conduct their own research and consult with professional advisors before making any investment decisions.Past performance is not indicative of future results. The host, guests, and producers of this podcast may hold positions in the securities discussed. This podcast may contain forward-looking statements that are subject to risks and uncertainties. Actual results may differ materially from those projected in these forward-looking statements.Investing in securities involves risk, including the potential loss of principal. Please be aware that the stock market can be volatile and investment values can fluctuate.By listening to this podcast, you agree to not hold the host, guests, producers, or any affiliated companies liable for any investment decisions you make.Always do your own due diligence and invest responsibly.

Got something to say to this podcast? Send a voicemail, and you might hear yourself on the next episode!On this episode of The Harvest Podcast, Carmel Fisher sits down with Giorgio R. Saumat, Chairman and CEO of Earth Science Tech, Inc. (OTC: ETST), to discuss the company’s disciplined operating model and long‑term growth strategy. Saumat outlines ETST’s vertically integrated healthcare platform—spanning telehealth, compounding pharmaceuticals, and patient fulfillment—while emphasizing the company’s strong balance sheet, positive cash flow, and multi‑year track record of avoiding dilutive capital raises.The conversation also explores ETST’s diversification initiatives, profitability trajectory, and readiness for scaled expansion as the company positions itself for a potential uplist. For investors and stakeholders seeking clarity on ETST’s operational focus and capital‑markets strategy, this discussion offers a clear, grounded view of where the company is headed.Learn More: www.harvestcomms.comDisclaimer:The Harvest podcast is for informational and educational purposes only. The views and opinions expressed in this podcast are those of the hosts and guests and do not necessarily reflect the official policy or position of any company or institution mentioned. The content of this podcast does not constitute investment, legal, or tax advice.Investing in securities involves risk, including the potential loss of principal. Please be aware that the stock market can be volatile and investment values can fluctuate. By listening to this podcast, you agree to not hold the host, guests, producers, or any affiliated companies liable for any investment decisions you make.Always do your own due diligence and invest responsibly.

Got something to say to this podcast? Send a voicemail, and you might hear yourself on the next episode!The Panguna Mine in Bougainville contains an estimated $100 billion in proven copper and gold reserves; nearly 1% of global gold reserves and copper resources equal to 70% of Canada's total. Shuttered since 1989 due to civil war, it remains one of the world's largest undeveloped ore bodies. In this extraordinary conversation, Numa Numa Resources Chairman & CEO John D. Kuhns explains how his company secured what no other mining firm has achieved: binding agreements with the Panguna landowners and Bougainville's government to develop the mine.John D. Kuhns, Chairman & CEO of Numa Numa Resources, discusses his company's unprecedented agreements to develop Bougainville's Panguna Mine (a $100 billion copper-gold resource that's been shuttered since 1989). Kuhns explains how decade-long relationships with landowner clans create competitive advantages traditional miners can't replicate, addresses sovereignty risk as Bougainville pursues independence from Papua New Guinea, and reveals why China's strategic interest in the region makes Western investment urgent. Topics include capital requirements for mine restart, profit-sharing structures, Numa Numa's planned public listing, and why this tier-one asset is positioned to help fill the looming global copper supply gap. A geopolitically charged conversation about resources, independence, and frontier market opportunity.Perfect for: Resource investors, geopolitical analysts, family offices evaluating frontier market opportunities, institutional investors interested in copper-gold exposure, and anyone tracking U.S.-China strategic competition in the Pacific.Critical Context: Goldman Sachs projects gold at $4,900/oz by December 2026. Global copper demand is set to double by 2035 with supply pipelines critically constrained. The Panguna Mine's 547.15 metric tons of gold and 5.3 million metric tons of copper are proven reserves—not exploration targets. This isn't a speculative junior miner; it's a fully explored, previously producing tier-one asset in a geopolitically strategic location.Disclaimer:The Harvest podcast is for informational and educational purposes only. The views and opinions expressed in this podcast are those of the hosts and guests and do not necessarily reflect the official policy or position of any company or institution mentioned. The content of this podcast does not constitute investment, legal, or tax advice.Investing in securities involves risk, including the potential loss of principal. Please be aware that the stock market can be volatile and investment values can fluctuate. By listening to this podcast, you agree to not hold the host, guests, producers, or any affiliated companies liable for any investment decisions you make.Always do your own due diligence and invest responsibly.

Got something to say to this podcast? Send a voicemail, and you might hear yourself on the next episode!Join us for an exclusive conversation with John Lai, CEO of PetVivo Holdings, Inc. (NASDAQ: PETV), as we explore how this biomedical device company is positioning itself at the intersection of veterinary therapeutics and the explosive AI-driven preventive pet care revolution.What You'll Discover:How Spryng, PetVivo's intra-articular injection for managing lameness and osteoarthritis in dogs and horses, is penetrating the veterinary clinic marketThe strategic significance of the Digital Landia partnership and what AgenticPet's viral adoption (1,000+ beta users in under 72 hours) means for PetVivo's distribution strategyWhy the shift from reactive to preventive pet care creates a massive tailwind for PetVivo's commercial expansion across 8,500+ potential veterinary clinic partnersEXCLUSIVE: Lai's roadmap for scaling beyond the company's lead product into both veterinary and human clinical applicationsHow PetVivo plans to capture value from the convergence of AI diagnostics and therapeutic interventions in the $30+ billion pet healthcare marketLai reveals the company's capital allocation strategy, pipeline priorities, and competitive advantages as veterinary medicine undergoes its biggest transformation in decades. With pet owners demonstrating unprecedented demand for proactive health solutions, discover why PetVivo believes it's positioned to deliver both better patient outcomes and sustainable shareholder returns.Host: Carmel FisherPerfect for: Healthcare investors, veterinary industry professionals, biomedical device sector analysts, and anyone tracking the intersection of AI and animal health.Key Topics: Veterinary therapeutics, biomedical devices, osteoarthritis treatment, AI-driven diagnostics, preventive care models, veterinary clinic distribution, pet healthcare market dynamics, strategic partnershipsThis episode examines how established therapeutic companies can leverage emerging AI platforms to accelerate market penetration and create new revenue opportunities.Meet the team in person:DealFlow Discovery Conference,Borgata Hotel, Casino and Spa (Atlantic City, NJ) - Jan. 28-29, 2026Disclaimer:The Harvest podcast is for informational and educational purposes only. The views and opinions expressed in this podcast are those of the hosts and guests and do not necessarily reflect the official policy or position of any company or institution mentioned. The content of this podcast does not constitute investment, legal, or tax advice.Investing in securities involves risk, including the potential loss of principal. Please be aware that the stock market can be volatile and investment values can fluctuate. By listening to this podcast, you agree to not hold the host, guests, producers, or any affiliated companies liable for any investment decisions you make.Always do your own due diligence and invest responsibly.

Got something to say to this podcast? Send a voicemail, and you might hear yourself on the next episode!SafeSpace Global Corporation (OTCID: SSGC) achieved something remarkable in 2025—transforming from Healthcare Integrated Technologies into a multi-vertical, multimodal AI safety platform with verticals spanning education, transportation, senior living, and correctional facilities.The mission is simple: Save Lives!In this exclusive, investor-focused conversation with host Carmel Fisher, President & Chief Strategy Officer Dustin Hillis reveals the strategy behind their breakout year.Hillis discusses landing the Kansas City transit deployment ahead of FIFA World Cup 2026, securing exclusive U.S. rights, upon definitive agreements, to BMRT's molecular-level weapons detection technology through an initial Letter of Intent, and building the unified school safety ecosystem with 911inform that targets 130,000+ American schools.Hillis explains how SafeSpace maintains execution excellence across diverse verticals, why strategic partnerships accelerate growth faster than building in-house, and what investors need to know about the company's planned 2026 uplisting to a national securities exchange.From recurring SaaS revenue models and unit economics to competitive moats and why early investors have a pre-uplisting opportunity, this conversation covers the complete investment thesis.Dustin hints at financial metrics, deployment pipelines, and strategic initiatives they'll be discussing in detail with investors at the upcoming DealFlow Discovery conference.Key Topics:Why KCATA chose SafeSpace over established security providers for FIFA World Cup 2026How the 911inform partnership creates a multi-billion-dollar school safety opportunityWhat "exclusive molecular detection rights" means for competitive positioning and valuationThe business model: SaaS subscriptions, customer retention, and path to profitabilityUplisting timeline, governance readiness, and why investor timing matters nowHealthcare foundation with Signature HealthCARE and proven multimodal AI technologyGuests: Dustin Hillis – President & CSO, SafeSpace Global Corp.Learn more: www.safespaceglobal.aiInvestor contact:[email protected] the team in person:DealFlow Discovery Conference,Borgata Hotel, Casino and Spa (Atlantic City, NJ) - Jan. 28-29, 2026Disclaimer:The Harvest podcast is for informational and educational purposes only. The views and opinions expressed in this podcast are those of the hosts and guests and do not necessarily reflect the official policy or position of any company or institution mentioned. The content of this podcast does not constitute investment, legal, or tax advice.Investing in securities involves risk, including the potential loss of principal. Please be aware that the stock market can be volatile and investment values can fluctuate. By listening to this podcast, you agree to not hold the host, guests, producers, or any affiliated companies liable for any investment decisions you make.Always do your own due diligence and invest responsibly.

Got something to say to this podcast? Send a voicemail, and you might hear yourself on the next episode!This episode features an investor-focused discussion (as usual) with Executive Chairman & CEO Dr. Greg Campbell and CFO Jeff Clayborne of Newton Golf Company Inc. (NASDAQ: NWTG), examining the company's triple-digit Q3 growth and expanding market presence.Campbell reveals how Newton Golf is disrupting the mature golf equipment market through physics-first innovation, including the breakthrough Fast Motion Shaft—a 10-gram lighter design capitalizing on industry-wide trends toward lighter equipment. The company's technology serves both Tour professionals seeking incremental gains and amateurs looking for game improvement, creating a broad addressable market within the performance equipment segment.The leadership team details Newton's marketing flywheel effect, where strategic investments in digital advertising are generating over $4 in revenue for every dollar spent—a ratio that continues improving as the company scales. This efficient customer acquisition model, combined with proprietary shaft and putter technologies, positions Newton to capture increasing market share in the premium golf equipment category.Join host Carmel Fisher for an in-depth exploration of Newton Golf's strategic expansion, technology differentiation, and the operational metrics driving sustained triple-digit growth in a competitive marketplace.The Harvest Podcast showcases companies transforming traditional business practices within their industries.Disclaimer:The Harvest podcast is for informational and educational purposes only. The views and opinions expressed in this podcast are those of the hosts and guests and do not necessarily reflect the official policy or position of any company or institution mentioned. The content of this podcast does not constitute investment, legal, or tax advice.Any strategies or investment ideas discussed may not be suitable for all investors. Listeners should conduct their own research and consult with professional advisors before making any investment decisions. Past performance is not indicative of future results.The host, guests, and producers of this podcast may hold positions in the securities discussed. This podcast may contain forward-looking statements that are subject to risks and uncertainties. Actual results may differ materially from those projected in these forward-looking statements.Investing in securities involves risk, including the potential loss of principal. Please be aware that the stock market can be volatile and investment values can fluctuate. By listening to this podcast, you agree to not hold the host, guests, producers, or any affiliated companies liable for any investment decisions you make.Always do your own due diligence and invest responsibly.

Got something to say to this podcast? Send a voicemail, and you might hear yourself on the next episode!What happens when a board-certified physician gets fed up spending half his day sorting through insurance PDFs? He builds a $490 billion solution.In this revealing episode, Shane Speirs, MD, MBA—CEO of Adageis—pulls back the curtain on how his fintech AI platform is capturing the massive wave of value-based care adoption sweeping through healthcare. With over 580,000 patient lives already on the platform and aggressive growth targets ahead, Speirs breaks down the economics that make investors pay attention.WATCH NOW!You'll discover:Why Adageis's per-provider-per-month SaaS model is perfectly positioned for the value-based care transitionHow their patented Risk Engine and AI Scribe technology create defensible competitive advantagesThe strategy behind their AthenaHealth marketplace partnership and what it means for customer acquisition costsDetails on their medical receivables financing model and how it diversifies revenue streamsReal numbers: from 150,000 to 580,000 patient lives—what's driving this 4x growth trajectoryIf you're looking to understand where healthcare technology meets tangible ROI, this conversation delivers. Speirs doesn't just talk about disrupting healthcare—he's living it, scaling it, and making it profitable.The future of healthcare finance is here. Are you positioned to capitalize on it?Disclaimer:The Harvest podcast is for informational and educational purposes only. The views and opinions expressed in this podcast are those of the hosts and guests and do not necessarily reflect the official policy or position of any company or institution mentioned. The content of this podcast does not constitute investment, legal, or tax advice.Any strategies or investment ideas discussed may not be suitable for all investors. Listeners should conduct their own research and consult with professional advisors before making any investment decisions. Past performance is not indicative of future results.The host, guests, and producers of this podcast may hold positions in the securities discussed. This podcast may contain forward-looking statements that are subject to risks and uncertainties. Actual results may differ materially from those projected in these forward-looking statements.Investing in securities involves risk, including the potential loss of principal. Please be aware that the stock market can be volatile and investment values can fluctuate. By listening to this podcast, you agree to not hold the host, guests, producers, or any affiliated companies liable for any investment decisions you make.Always do your own due diligence and invest responsibly.

Got something to say to this podcast? Send a voicemail, and you might hear yourself on the next episode!What happens when you combine AI-powered robotics with strategic hotel acquisitions? You get Nightfood Holdings (OTCQB: NGTF)—a company pioneering a first-of-its-kind dual growth engine that's catching serious investor attention.In this episode, President Ried Floco and CEO Jimmy Chan reveal how NGTF is leveraging 35+ years of hospitality expertise to deploy Robotics-as-a-Service (RaaS) solutions in real-world environments before scaling across multiple industries. Unlike pure-play tech companies, Nightfood owns its testing grounds—acquiring hotels that serve as innovation hubs while generating asset-backed revenue.Key Investment Highlights Discussed:Why NGTF's operational-first approach beats tech-first competitorsThe strategic advantage of owned deployment sites for validation and credibilityHow the company positions itself at the intersection of two massive markets: the ~$107B service robotics sector and the ~$181B smart hospitality marketThe 3-5 year vision for portfolio expansion and cross-industry RaaS scalingRisk mitigation through tangible real estate assets paired with subscription revenueWhether you're evaluating early-stage automation plays or looking for differentiated exposure to the robotics revolution, this conversation offers rare insight into a company building infrastructure for the future of work—one hotel at a time.Perfect for: Growth investors, automation sector analysts, hospitality tech enthusiasts, and anyone tracking the convergence of AI, robotics, and real asset acquisition strategies.Disclaimer:The Harvest podcast is for informational and educational purposes only. The views and opinions expressed in this podcast are those of the hosts and guests and do not necessarily reflect the official policy or position of any company or institution mentioned.The content of this podcast does not constitute investment, legal, or tax advice. Any strategies or investment ideas discussed may not be suitable for all investors. Listeners should conduct their own research and consult with professional advisors before making any investment decisions.Past performance is not indicative of future results. The host, guests, and producers of this podcast may hold positions in the securities discussed. This podcast may contain forward-looking statements that are subject to risks and uncertainties. Actual results may differ materially from those projected in these forward-looking statements.Investing in securities involves risk, including the potential loss of principal. Please be aware that the stock market can be volatile and investment values can fluctuate.By listening to this podcast, you agree to not hold the host, guests, producers, or any affiliated companies liable for any investment decisions you make.Always do your own due diligence and invest responsibly.